Immune SupportStudiedCompoundableS

VIP

Vasoactive Intestinal Peptide · VPAC1 and VPAC2 receptor agonism; cAMP elevation via adenylyl cyclase; promotes Th2 tolerance over Th1/Th17 inflammatory responses; inhibits TNF-α, IL-12, and iNOS production; causes smooth muscle relaxation and bronchodilation

Last reviewed . First published . By the PeptIQ team.

Educational and observational reference only. Not medical advice. Community charts use live PeptIQ self-reports.

Studies cited
11
Research grade
S
Experience
12

Overall check-ins

Activity
58

Trackers & reports

Typical Dose

50 mcg intranasally twice daily (CIRS protocol) or 200–400 ng/kg IV infusion

Route

Intranasal / Injectable

Cycle

Protocol-dependent (CIRS: months of therapy)

Storage

2–8°C Refrigerated

What is VIP?

Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide naturally expressed throughout the nervous system, gut, and immune tissues. It functions as a potent immunomodulator, bronchodilator, and vasodilator. Clinically researched for inflammatory bowel disease, pulmonary arterial hypertension, sarcoidosis, autoimmune conditions, and CIRS (Chronic Inflammatory Response Syndrome). Available through compounding pharmacies with a prescription.

Mechanism of Action

VPAC1 and VPAC2 receptor agonism; cAMP elevation via adenylyl cyclase; promotes Th2 tolerance over Th1/Th17 inflammatory responses; inhibits TNF-α, IL-12, and iNOS production; causes smooth muscle relaxation and bronchodilation

Target: VPAC1 receptor, VPAC2 receptor

Research Indications

Immune ModulationEffective

Research shows modulation of immune cell activity and inflammatory response

Inflammation ControlEffective

May reduce systemic and localized inflammatory markers

Infection ResistanceModerate

Some evidence for improved pathogen defense mechanisms

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting Dose250 mcg3x weeklySubcutaneous injection
Maintenance Dose500 mcgWeeklySubcutaneous injection

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Consult prescriber before combining with any medicationCaution
BPC-157Compatible
NAD+Compatible
Vitamin DCompatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove VIP vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Initial effects and adaptation period. Monitor for any adverse reactions.

Week 2–4

Primary effects begin to manifest. Adjust dosing as recommended by your provider.

Week 4–8

Main therapeutic effects should be established. Assess progress with your provider.

Week 8+

Evaluate results and determine continuation, cycling, or dose adjustments.

Side Effects & Safety

  • Injection site reactions (redness, bruising, mild pain)
  • Potential for allergic reaction — discontinue if rash or hives occur
  • Individual reactions vary — start at the lowest dose and monitor carefully
  • Consult your healthcare provider before use and report any unusual symptoms

FDA Status & Regulatory Info

Compoundable

Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide naturally expressed throughout the nervous system, gut, and immune tissues. It functions as a potent immunomodulator, bronchodilator, and vasodilator. Clinically researched for inflammatory bowel disease, pulmonary arterial hypertension, sarcoidosis, autoimmune conditions, and CIRS (Chronic Inflammatory Response Syndrome). Available through compounding pharmacies with a prescription.

Rx Required: Yes
503A Ban: No
Telehealth: Available
Full FDA Status Tracker

Frequently Asked Questions

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

What 25 users report

Observational self-reports from live PeptIQ aggregates. Not clinical outcomes.

25 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 2% · Mixed 2% · Unfavorable overall 96%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Recovery
163
Energy
6

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Nausea
83
Headache
77

Self-reported dose per injection

Median bucket: 50–100 mcg · Most common: 50–100 mcg

Reports span 50–200 mcg

50–100
116
100–200
47

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 88% said they felt similar to their last entry, 13% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 152 days · Based on 24 repeat reporters

Share Your Experience

Rate VIP in the PeptIQ app and help the community make informed decisions.

Research References (9)

Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.

  1. PubMed

    Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension

    Ghatei MA, Takahashi K, Suzuki H, et al. J Cardiovasc Pharmacol. 2003

    Source
    Wiki study page →
  2. PubMed

    Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo

    Delgado M, Chorny A, Gonzalez-Rey E, et al. J Leukoc Biol. 2005

    Source
    Wiki study page →
  3. PubMed

    Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions

    Delgado M, Ganea D. Amino Acids. 2013

    Source
    Wiki study page →
  4. PubMed

    Vasoactive intestinal peptide: cardiovascular effects

    Henning RJ, Sawmiller DR. Cardiovascular Research. 2001

    Source
    Wiki study page →
  5. PubMed

    Vasoactive intestinal peptide and the mammalian circadian system

    Vosko AM, Schroeder A, Loh DH, et al. General and Comparative Endocrinology. 2007

    Source
    Wiki study page →
  6. PubMed

    New perspectives on vasoactive intestinal polypeptide as a widespread modulator of social behavior

    Kingsbury MA. Current Opinion in Behavioral Sciences. 2015

    Source
    Wiki study page →
  7. ClinicalTrials.gov

    Vasoactive Intestinal Peptide studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  8. PubMed

    The significance of vasoactive intestinal peptide in immunomodulation

    Delgado M, Pozo D, Ganea D. Pharmacological reviews. 2004

    Source
    Wiki study page →
  9. PubMed

    Role of vasoactive intestinal peptide in osteoarthritis

    Jiang W, Wang H, Li YS, et al. Journal of biomedical science. 2016

    Source
    Wiki study page →

Wiki tools

Observational indexes and compare views for VIP.

Educational information only

This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

PeptIQ app

Log your VIP protocol in PeptIQ

Turn this VIP guide into a living protocol — doses, vials, and history in one place.

Track VIPOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Quick Facts

Half-Life
~1–2 minutes (plasma)
Target
VPAC1 receptor, VPAC2 receptor
Route
Intranasal / Injectable
Availability
Pharmacy & Telehealth
Rx Required
Yes
503A Ban
No
Browse peptide education

Talk with a clinician

PeptIQ is education only. We do not sell peptides or list vendors. Discuss VIP with a licensed healthcare provider — not medical advice, not a prescription.

Download PeptIQ

Wiki tools

Observational indexes and compare views for VIP.